Nanovibronix, Inc. (NASDAQ:FEED) Short Interest Up 165.7% in July

Nanovibronix, Inc. (NASDAQ:FEED) saw a significant increase in short interest during the month of July. As of July 15th, there was short interest totaling 161,665 shares, an increase of 165.7% from the June 30th total of 60,839 shares. Currently, 2.7% of the shares of the company are sold short. Based on an average daily volume of 507,400 shares, the days-to-cover ratio is presently 0.3 days.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on the company. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Nanovibronix in a report on Tuesday, July 21st. Wall Street Zen upgraded Nanovibronix from a “strong sell” rating to a “sell” rating in a report on Sunday, July 12th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Nanovibronix currently has a consensus rating of “Sell”.

Insider Activity

In other news, insider Christian Michael Glibert sold 210,000 shares of Nanovibronix stock in a transaction dated Monday, June 22nd. The stock was sold at an average price of $0.69, for a total value of $144,900.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.40% of the company’s stock.

Nanovibronix Price Performance

FEED stock traded down $0.02 during trading on Tuesday, reaching $0.34. 87,213 shares of the stock were exchanged, compared to its average volume of 5,892,306. Nanovibronix has a twelve month low of $0.33 and a twelve month high of $17.40. The firm has a market capitalization of $2.05 million, a P/E ratio of -0.04 and a beta of 1.56. The business’s 50 day simple moving average is $0.67.

Nanovibronix (NASDAQ:FEED) last posted its quarterly earnings results on Monday, May 18th. The company reported ($6.88) EPS for the quarter. Nanovibronix had a negative net margin of 923.20% and a negative return on equity of 54.25%. The firm had revenue of $0.65 million during the quarter.

About Nanovibronix

Nanovibronix (NASDAQ: FEED) is a medical device company focused on the development and commercialization of non‑invasive therapeutic ultrasound technologies for clinical and consumer healthcare applications. The company’s product portfolio centers on wearable ultrasound devices designed to deliver low‑intensity acoustic energy to soft tissue with the objective of promoting wound healing and reducing pain. Nanovibronix positions its technology as an alternative or adjunct to conventional wound‑care and analgesic therapies, aiming to address chronic and acute conditions that are managed in both outpatient and home settings.

The company concentrates its commercial efforts on supplying hospitals, wound‑care clinics, long‑term care facilities and patients requiring home‑based therapies.